Genetic factors for race related prostate cancer.
Genetic factors for race related prostate cancer.
批准号:
9314426
负责人:
RAJVIR DAHIYA
金额:
$31.81万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-07-01 至 2020-06-30
关键词:
3&apos Untranslated Regions5&apos Untranslated RegionsAddressAfricanAfrican AmericanAge of OnsetApoptosisBenignBindingBiological AssayCaucasiansCell CycleCell LineClinicalCpG IslandsDNA MethylationDNA Modification MethylasesDNA copy numberDNA sequencingDNMT3B geneDNMT3aDataDiagnosisGene TargetingGenesGeneticGenetic MarkersGoalsHistone AcetylationHumanIn Situ HybridizationIn VitroIncidenceLuciferasesMalignant NeoplasmsMalignant neoplasm of prostateMediatingMessenger RNAMetastatic Neoplasm to the BoneMethodsMethylationMicroRNAsMolecularMolecular Mechanisms of ActionMolecular ProfilingMonitorNatureOncogenesOncogenicPopulationPromoter RegionsProstatePublic HealthRaceRepressionRoleSamplingScreening for Prostate CancerSeriesSuppressor GenesTechniquesTestingTimeTissuesTumor Suppressor GenesTumor Suppressor ProteinsUnited Statesadvanced diseasebasecancer health disparitycell growthclinically significantdemographicsdifferential expressionexperimental studyhistone modificationinnovationmenmiRNA expression profilingmortalitynoveloverexpressionpublic health relevanceracial disparitysodium bisulfitetherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The major problem or barrier is that there are currently no methods or approaches to adequately address prostate cancer health disparity in African Americans. A major question is why do African American men have a higher overall incidence, earlier age of onset, increased proportion of clinically advanced disease and increased bone metastases and mortality from prostate cancer compared to Caucasians? The main goal of this project is to investigate the genetic basis of prostate cancer health disparities The rationale is that prostate cancer is the leading cancer among men of African descent in the USA. Despite more aggressive screening of prostate cancer across all demographics in the United States, disparities among populations persist. A substantial proportion of African American men have a higher overall incidence, earlier age of onset, increased proportion of clinically advanced disease and increased bone metastases and mortality from prostate cancer compared to Caucasians. There are racial disparities in survival after diagnosis of prostate cancer in men. Therefore, prostate cancer incidence and mortality represent a significant public health problem in African American men. Recent studies have shown that miRNAs are significantly altered in prostate cancer. Based on our preliminary data, we hypothesize that the differential expression profile of a set of oncogenic miRNAs and tumor suppressor miRNAs in African Americans may target a set of prostate cancer specific genes and may contribute to the prostate cancer health disparity in African Americans. The molecular mechanisms of action of tumor suppressor miRNAs are through repressing oncogenes and activating tumor suppressor genes. We will test these hypotheses through analyses of a series of experiments proposed under our specific aims. All the aims are highly focused, centralized, innovative, clinically significant, functional and mechanistic in nature. Specific Aim # 1. Investigate the role of miRNAs as the genetic basis of prostate cancer health disparity in African Americans as compared to Caucasians. Specific Aim # 2. Investigate the functional significance and molecular mechanisms of action of oncogenic and tumor suppressor miRNAs in race-related prostate cancer. Specific Aim # 3. Investigate the molecular mechanisms of differential expression of miRNAs in African Americans and Caucasians. Impact: The present application has high impact because it describes a novel concept and approach that is different and better from the previous attempts since differential expression of a set of miRNAs may explain why African Americans have higher incidence of prostate cancer compared to Caucasians. This project will identify novel miRNAs that can be used as genetic biomarkers and potential therapeutic targets for race-related prostate cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BLR&D Research Career Scientist Award Application
-
批准号:10047723
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:RAJVIR DAHIYA
-
依托单位:
Molecular biomarkers for kidney cancer prognosis using non-coding RNAs
-
批准号:9270533
-
项目类别:
-
资助金额:$35.07万
-
财政年份:2016
-
负责人:RAJVIR DAHIYA
-
依托单位:
Molecular biomarkers for kidney cancer prognosis using non-coding RNAs
-
批准号:9052372
-
项目类别:
-
资助金额:$35.07万
-
财政年份:2016
-
负责人:RAJVIR DAHIYA
-
依托单位:
Genetic factors for race related prostate cancer.
-
批准号:8874808
-
项目类别:
-
资助金额:$31.81万
-
财政年份:2015
-
负责人:RAJVIR DAHIYA
-
依托单位:
Role of genetic biomarkers in clinical assessment of prostate cancer
-
批准号:8246285
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:RAJVIR DAHIYA
-
依托单位:
Role of genetic biomarkers in clinical assessment of prostate cancer
-
批准号:8764702
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:RAJVIR DAHIYA
-
依托单位:
Role of genetic biomarkers in clinical assessment of prostate cancer
-
批准号:8598789
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:RAJVIR DAHIYA
-
依托单位:
Chemo-dietary prevention, miRNAs, epigenetic and prostate cancer
-
批准号:8149764
-
项目类别:
-
资助金额:$46.14万
-
财政年份:2011
-
负责人:RAJVIR DAHIYA
-
依托单位:
Chemo-dietary prevention, miRNAs, epigenetic and prostate cancer
-
批准号:8658043
-
项目类别:
-
资助金额:$44.17万
-
财政年份:2011
-
负责人:RAJVIR DAHIYA
-
依托单位:
Genistein, microRNAs and kidney cancer
-
批准号:8598022
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:RAJVIR DAHIYA
-
依托单位:
Chemo-dietary prevention, miRNAs, epigenetic and prostate cancer
-
批准号:8298153
-
项目类别:
-
资助金额:$45.94万
-
财政年份:2011
-
负责人:RAJVIR DAHIYA
-
依托单位:
Genistein, microRNAs and kidney cancer
-
批准号:8139669
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:RAJVIR DAHIYA
-
依托单位:
Genistein, microRNAs and kidney cancer
-
批准号:8391641
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:RAJVIR DAHIYA
-
依托单位:
Chemo-dietary prevention, miRNAs, epigenetic and prostate cancer
-
批准号:8458611
-
项目类别:
-
资助金额:$42.99万
-
财政年份:2011
-
负责人:RAJVIR DAHIYA
-
依托单位:
MicroRNAs in the Progression and Metastisis of Prostate Cancer
-
批准号:8434008
-
项目类别:
-
资助金额:$49.56万
-
财政年份:2010
-
负责人:RAJVIR DAHIYA
-
依托单位:
MicroRNAs in the Progression and Metastisis of Prostate Cancer
-
批准号:7782806
-
项目类别:
-
资助金额:$54.93万
-
财政年份:2010
-
负责人:RAJVIR DAHIYA
-
依托单位:
MicroRNAs in the Progression and Metastisis of Prostate Cancer
-
批准号:8607511
-
项目类别:
-
资助金额:$50.9万
-
财政年份:2010
-
负责人:RAJVIR DAHIYA
-
依托单位:
MicroRNAs in the Progression and Metastisis of Prostate Cancer
-
批准号:8058712
-
项目类别:
-
资助金额:$53.19万
-
财政年份:2010
-
负责人:RAJVIR DAHIYA
-
依托单位:
MicroRNAs in the Progression and Metastisis of Prostate Cancer
-
批准号:8212579
-
项目类别:
-
资助金额:$52.97万
-
财政年份:2010
-
负责人:RAJVIR DAHIYA
-
依托单位:
Wnt antagonist genes in kidney tumor progression and metastasis
-
批准号:8256587
-
项目类别:
-
资助金额:$60.13万
-
财政年份:2008
-
负责人:RAJVIR DAHIYA
-
依托单位:
海外基金